摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[(Dimethylamino)methyl]-4-(quinazolin-4-ylamino)phenol | 945989-88-8

中文名称
——
中文别名
——
英文名称
3-[(Dimethylamino)methyl]-4-(quinazolin-4-ylamino)phenol
英文别名
——
3-[(Dimethylamino)methyl]-4-(quinazolin-4-ylamino)phenol化学式
CAS
945989-88-8
化学式
C17H18N4O
mdl
——
分子量
294.356
InChiKey
NGLFRXMHNOLGEX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    61.3
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    3-[(Dimethylamino)methyl]-4-(quinazolin-4-ylamino)phenol1-溴-3-氯丙烷caesium carbonate 作用下, 以 丙酮 为溶剂, 反应 5.0h, 以93%的产率得到N-[4-(3-chloropropoxy)-2-[(dimethylamino)methyl]phenyl]quinazolin-4-amine
    参考文献:
    名称:
    A new class of histamine H3 receptor antagonists derived from ligand based design
    摘要:
    Design and synthesis of highly potent and selective non-imidazole inverse agonists for the histamine H-3 receptor is described. The study validates a new pharmacophore model based on the merging of two previously described models. It also demonstrates that the removal of the basic center potentially interacting with ASP3.32 and common to both models leads to loss of activity, whereas the replacement of the second basic center by an acceptor retains the potency. 14 (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.04.056
  • 作为产物:
    描述:
    N-(4-(benzyloxy)-2-((dimethylamino)methyl)phenyl)quinazolin-4-amine 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 以83%的产率得到3-[(Dimethylamino)methyl]-4-(quinazolin-4-ylamino)phenol
    参考文献:
    名称:
    A new class of histamine H3 receptor antagonists derived from ligand based design
    摘要:
    Design and synthesis of highly potent and selective non-imidazole inverse agonists for the histamine H-3 receptor is described. The study validates a new pharmacophore model based on the merging of two previously described models. It also demonstrates that the removal of the basic center potentially interacting with ASP3.32 and common to both models leads to loss of activity, whereas the replacement of the second basic center by an acceptor retains the potency. 14 (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.04.056
点击查看最新优质反应信息

文献信息

  • A new class of histamine H3 receptor antagonists derived from ligand based design
    作者:Olivier Roche、Rosa María Rodríguez Sarmiento
    DOI:10.1016/j.bmcl.2007.04.056
    日期:2007.7
    Design and synthesis of highly potent and selective non-imidazole inverse agonists for the histamine H-3 receptor is described. The study validates a new pharmacophore model based on the merging of two previously described models. It also demonstrates that the removal of the basic center potentially interacting with ASP3.32 and common to both models leads to loss of activity, whereas the replacement of the second basic center by an acceptor retains the potency. 14 (c) 2007 Elsevier Ltd. All rights reserved.
查看更多